12 results
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... algorithms by Global ... indicate preferred treatment ... Management #Pulmonary #COPD ... #LABA #ICS #Guidelines
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Algorithm for Chronic ... pulmonary disease (COPD ... #COPD #Treatment ... #Algorithm #Management ... #ICS #Pharmacology
First-line therapies for Asthma, Asthma-COPD Overlap and COPD

The diagnosis of COPD, asthma, and ACO initially requires
first-line therapies is ... overlap; ICS = ... corticosteroids; LABA ... #Differences #Algorithm ... #Treatment
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Reduce risk of COPD ... /LABA/ICS) - ... /LABA) & Eosinophils ... recommendations for the treatment ... #Indications #Pharmacology
LABA/ICS Combination Inhalers
Long-Acting Beta2 Agonists (LABA) + Inhaled Corticosteroid (ICS) - Commonly used in Asthma 
Advair
LABA/ICS Combination ... of a patients COPD ... posts for the COPD ... treatment algorithm ... Naming #Names #Pharmacology
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
lab markers such ... the treatment goal ... #differential #algorithm ... #heartfailure #chf ... #clinical #pharmacology
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Triggers: ATRA treatment ... Pathophysiology ... Diagnosis: • Labs ... sepsis), PE, DAH, CHF ... organ dysfuxtion, ICU
Guillain-Barré Syndrome (GBS)
Acute autoimmune demyelinating polyradiculoneuropathy that presents with rapidly progressive flaccid weakness
Epidemiology:
 • Incidence: 1
peripheral nerve components ... - Elevated CSF ... with a normal CSF ... the underlying pathophysiology ... and cauda equina TREATMENT
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Key Components: ... physical exam - Key components ... disease b) CHF ... event, follow ACC algorithm ... Determine if any labs
Stiff Person Syndrome (SPS) - Diagnosis and Management Summary

Epidemiology:
 • Prevalence: 1-2 cases per million -
Person Syndrome Pathophysiology ... indicates that it is ... brain and spinal cord ... EMG testing Lab ... • CSF: Oligoclonal